This article delves into the transformative role of Agatston scores in predicting coronary heart disease. Leveraging cutting-edge medical technology, researchers are recalibrating the approach to risk categorization, offering a new dawn in cardiovascular health management.
Read MoreA retrospective study of U.S. veterans with newly diagnosed head and neck squamous cell carcinoma revealed suboptimal control of cardiovascular risk factors, leading to increased risk of stroke, myocardial infarction, and mortality. Black race was associated with a higher risk of uncontrolled risk factors. The findings underscore the need for targeted interventions to mitigate cardiac risk in this population.
Read MoreThe recently conducted POST-PCI trial examined the effectiveness of routine functional testing after percutaneous coronary intervention (PCI). The trial findings indicate that routine stress testing in the absence of symptoms does not prevent adverse cardiovascular events or provide additional value beyond standard care.
Read MoreEvidence highlights the need to re-establish quality metrics for low-density lipoprotein cholesterol (LDL-C) measurement and control. Despite the efficacy of LDL-C lowering in reducing cardiovascular disease risk, significant gaps exist in achieving recommended levels.
Read MoreA recent study published in JAMA Cardiology examines the use of percutaneous microaxial LVAD in patients with cardiogenic shock. While some analyses indicate worse outcomes compared to medical therapy and IABP, confounding variables limit conclusive findings.
Read More